Strategy for safety pharmacology studies in the course of clinical development

被引：0
|
作者：
Rochat, C. [1 ]
机构：
[1] IRIS, F-92415 Courbevoie, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] ANIMAL PHARMACOLOGY AND SAFETY STUDIES WITH AN LHRH AGONIST
    CORBIN, A
    BEX, FJ
    JOURNAL OF ANDROLOGY, 1987, 8 (01): : S9 - S13
  • [42] Integration of safety pharmacology endpoints into toxicology studies
    Luft, J
    Bode, G
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (02) : 91 - 103
  • [43] Statistical models for toxicity and safety pharmacology studies
    Andersen, H
    Spliid, H
    Larsen, S
    DRUG INFORMATION JOURNAL, 2000, 34 (02): : 631 - 643
  • [44] Safety pharmacology studies using EFP and impedance
    Obergrussberger, Alison
    Juhasz, Krisztina
    Thomas, Ulrich
    Stoelzle-Feix, Sonja
    Becker, Nadine
    Doerr, Leo
    Beckler, Matthias
    Bot, Corina
    George, Michael
    Fertig, Niels
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 223 - 232
  • [45] ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case Studies
    Darpo, Borje
    Borin, Marie
    Ferber, Georg
    Galluppi, Gerald R.
    Hopkins, Seth C.
    Landry, Ishani
    Lo, Arthur
    Rege, Bhaskar
    Reyderman, Larisa
    Sun, Lei
    Watanabe, Takao
    Xue, Hongqi
    Yasuda, Sally
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12): : 1480 - 1500
  • [46] Statistical Models for Toxicity and Safety Pharmacology Studies
    Helle Andersen
    Henrik Spliid
    Søren Larsen
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (2): : 631 - 643
  • [47] PRESENTING CLINICAL-PHARMACOLOGY AND THERAPEUTICS - THE COURSE IN PHARMACOTHERAPEUTICS
    DEVRIES, TPGM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (06) : 587 - 590
  • [48] An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil
    Murillo-Rodriguez, Eric
    Barciela Veras, Andre
    Barbosa Rocha, Nuno
    Budde, Henning
    Machado, Sergio
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (02): : 151 - 158
  • [49] Clinical pharmacology, efficacy and safety of atazanavir: a review
    Bentue-Ferrer, Daniele
    Arvieux, Cedric
    Tribut, Olivier
    Ruffault, Annick
    Bellissant, Eric
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (11) : 1455 - 1468
  • [50] Clinical pharmacology of MAO inhibitors: Safety and future
    Yamada, M
    Yasuhara, H
    NEUROTOXICOLOGY, 2004, 25 (1-2) : 215 - 221
12345